Live Breaking News & Updates on Fda Approval Of Repotrectinib

Stay updated with breaking news from Fda approval of repotrectinib. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Dr Velcheti on the FDA Approval of Repotrectinib in ROS1+ Metastatic NSCLC

Vamsidhar Velcheti, MD, discusses the significance of the FDA approval of the ROS1 TKI repotrectinib in patients with ROS1-positive metastatic non–small cell lung cancer. ....

Vamsidhar Velcheti , Department Of Medicine , York University , Langone Perlmutter Cancer Center , Grossman School Of Medicine , New York University , Grossman School , Perlmutter Cancer Center , New York University Grossman School Of Medicine , Nyu Langone Perlmutter Cancer Center , Fda Approval Of Repotrectinib , Patients With Ros1 Positive Metastatic Non Small Cell Lung Cancer ,